GLIDE方案治疗初发进展期及复发难治性结外鼻型NK/T细胞淋巴瘤的疗效评估

OBJECTIVE: To evaluate the efficacy of gemcitabine, asparaginase, ifosfamide, dexamethasone and etoposide (GLIDE) combination for patients with newly diagnosed advanced-stage or relapsed/refractory extranodal natural killer cell lymphoma (ENKL). METHODS: Fourty-two newly diagnosed advanced-stage or...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2016
Materias:
论著
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342113/
https://www.ncbi.nlm.nih.gov/pubmed/27719716
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.09.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342113/
https://www.ncbi.nlm.nih.gov/pubmed/27719716
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.09.005

Ejemplares similares